2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Date

Saturday, May 30, 2020

3:51pm-4:03pm: Kidney Alkalization Increases Macula Densa NOS1β Expression and Improves Transplanted Renal Graft Function

J. Buggs¹, J. Zhang², J. Wei², L. Wang²

Basic: Ischemia Reperfusion & Organ Rehabilitation I • Virtual

3:51pm-4:03pm: Liver Transplant Recipients with High DSA at Time of Transplant Do Not Have Increased Rejection or Mortality

A. Demirag¹, B. Rawashdeh¹, S. L. Lennon¹, S. Pelletier¹, J. Iezzoni², K. Khutsisvhili³, S. Shumilina¹, K. Chittum¹, J. Oberholzer¹, P. Lobo⁴

Liver: Immunosuppression and Rejection • Virtual

3:51pm-4:03pm: Living Kidney Donation is Associated with Accelerated Podocyte Loss Early after Donation

A. S. Naik, D. Le, S. Wang, M. Chowdhury, M. D. Doshi, R. Wiggins

Kidney Living Donor: Long Term Outcomes • Virtual

3:51pm-4:03pm: Long-Term Allograft Survival via Donor MHC Chimerism Induced by Exosomes

B. Gonzalez Nolasco, X. Wang, M. Wang, A. Prunevieille, K. M. Lee, J. F. Markmann, G. Benichou

Tolerance / Immune Deviation • Virtual

3:51pm-4:03pm: Long-Term Outcomes of Patients with Epstein-barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in an Expanded Access Program Study

S. Prockop¹, R. Reshaf², D. Tsai³, N. Bunin⁴, R. Abu-Arja⁵, K. Mahadeo⁶, W. Weng⁷, K. Van Besien⁸, D. Loeb⁹, S. Dwivedy Nasta¹⁰, E. Nemecek¹¹, M. Hiremath¹², S. Yue¹², Y. Sun¹², W. Navarro¹², S. Nikiforow¹³

PTLD/Malignancies • Virtual

3:51pm-4:03pm: Low HLA Class I Epitope Mismatch Associated with Improved Pancreas Graft Survival in Simultaneous Pancreas-Kidney Transplantation

J. M. Ladowski, M. Romine, D. Kloda, C. Young, J. Locke, V. Hauptfeld-Dolejsek, J. Houp

Histocompatibility and Immunogenetics • Virtual

3:51pm-4:03pm: Maintenance Steroids in the Setting of Alemtuzumab Induction Post-Kidney Transplant Increases Risk of Infection and Hospital Readmission

A. R. Webb, A. A. Al-Bahou, A. J. Brueckner, A. T. Logan, R. S. Baliga, L. J. Bowman Anger

Immunosuppressive Drug Minimization • Virtual

3:51pm-4:03pm: MELD is MELD is MELD? Geographic/ Center-Level Variation in Mortality for Patients with the Same MELD Score

T. Ishaque¹, A. B. Massie¹, A. B. Kernodle¹, S. Getsin¹, P. Chaing¹, J. G. Jacqueline Garonzik Wang¹, S. Gentry², D. Segev¹

Liver: MELD, Allocation and Donor Issues (DCD/ECD) II • Virtual

3:51pm-4:03pm: Mitochondrion-Endothelial Interaction Generates Danger Signal in Promoting Costimulation-Resistant T Cell-Mediated Allograft Rejection

S. Li¹, M. Song¹, Q. Li², A. Kirk¹, H. Xu¹

Endothelial Cell Biology • Virtual

3:51pm-4:03pm: Multi-Center, Open-Label Trial of Pre-Emptive Glecaprevir/Pibrentasvir (G/P) to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus (MYTHIC)

M. Sise¹, D. Goldberg², J. Kort³, D. Schaubel⁴, R. Alloway⁵, C. Durand⁶, R. Fontana⁷, J. Friedewald⁸, R. Brown⁹, S. Prenner¹⁰, R. Landis⁴, P. Reese¹¹, R. Chung¹

All Organs: Viral Hepatitis • Virtual